Is PHMMF or DIVO a better dividend investment in 2026?

PHMMF currently yields 0.97% with a 5% 5-year dividend growth rate. DIVO yields 4.00% with 5% growth. The better choice depends on your goal: DIVO offers higher current income.

What is the dividend yield difference between PHMMF and DIVO?

PHMMF has a forward dividend yield of 0.97% ($0.93/share annually). DIVO yields 4.00% ($2.00/share annually). The yield gap is 3.03 percentage points.

Home › Compare › PHMMF vs DIVO

PHMMF vs DIVO: Dividend Comparison 2026

PHMMF yields 0.97% · DIVO yields 4.00%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 PHMMF wins by $110.5K in total portfolio value· pulled ahead in Year 5

INVESTMENT

TIME HORIZON10 years

PHMMF

● Live price

0.97%

Share price

$96.00

Annual div

$0.93

5Y div CAGR

68.1%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$138.5K

Annual income

$65,086.57

Full PHMMF calculator →

DIVO

● Live price

4.00%

Share price

$50.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$28.0K

Annual income

$899.19

Full DIVO calculator →

Portfolio growth — PHMMF vs DIVO

📍 PHMMF pulled ahead of the other in Year 5

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	PHMMF	DIVO
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, PHMMF + DIVO cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

PHMMF pays

DIVO pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PHMMF

Annual income on $10K today (after 15% tax)

$82.26/yr

After 10yr DRIP, annual income (after tax)

$55,323.58/yr

DIVO

Annual income on $10K today (after 15% tax)

$340.00/yr

After 10yr DRIP, annual income (after tax)

$764.31/yr

At 15% tax rate, PHMMF beats the other by $54,559.27/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PHMMF + DIVO for your $10,000?

PHMMF: 50%DIVO: 50%

100% DIVO50/50100% PHMMF

Portfolio after 10yr

$83.3K

Annual income

$32,992.88/yr

Blended yield

39.61%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PHMMF buys

DIVO buys

No recent congressional trades found for PHMMF or DIVO in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricPHMMFDIVO

Forward yield	0.97%	4.00% ✓
Annual dividend / share	$0.93	$2.00 ✓
Payout ratio	50%	50%
1-year div growth	0%	5% ✓
5-year div CAGR	68.1% ✓	5%
Portfolio after 10y	$138.5K ✓	$28.0K
Annual income after 10y	$65,086.57 ✓	$899.19
Total dividends collected	$111.9K ✓	$6.4K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: PHMMF vs DIVO ($10,000, DRIP)

Year	PHMMF Portfolio	PHMMF Income/yr	DIVO Portfolio	DIVO Income/yr	Gap
1	$10,863	$162.67	$11,120	$420.00	$257.00 → DIVO
2	$11,901	$277.61	$12,357	$458.31	$456.00 → DIVO
3	$13,212	$477.81	$13,721	$499.76	$509.00 → DIVO
4	$14,970	$833.33	$15,227	$544.58	$257.00 → DIVO
5← crossover	$17,501	$1,483.41	$16,885	$593.02	+$616.00 → PHMMF
6	$21,451	$2,724.54	$18,713	$645.34	+$2.7K → PHMMF
7	$28,198	$5,246.31	$20,724	$701.81	+$7.5K → PHMMF
8	$41,007	$10,834.88	$22,938	$762.73	+$18.1K → PHMMF
9	$68,632	$24,753.88	$25,372	$828.41	+$43.3K → PHMMF
10	$138,522	$65,086.57	$28,047	$899.19	+$110.5K → PHMMF

PHMMF vs DIVO: Complete Analysis 2026

PHMMF — Stock

Pharma Mar, S.A., a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles of marine origin for use in oncology in Spain, Italy, Germany, Ireland, rest of EU, the United States, and internationally. The company operates through three segments: Oncology, Diagnostics, and RNA interference. It develops and commercializes Yondelis for the treatment of soft tissue sarcomas and for ovarian cancer; Aplidin for treating multiple myeloma; and Zepzelca for treating patients with small cell lung cancer. The company also develops PM14 which is in phase II clinical trails for the treatment of solid tumors. In addition, it develops and markets diagnostics kits; and develops drugs with therapeutic activity based on reducing or silencing gene expression. The company was incorporated in 1986 and is based in Madrid, Spain.

Full PHMMF Calculator →

DIVO — ETF

DIVO is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in DIVO shares.

Full DIVO Calculator →

📬

Get this PHMMF vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PHMMF vs SCHD PHMMF vs JEPI PHMMF vs O PHMMF vs KO PHMMF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.